𝔖 Bobbio Scriptorium

✦ LIBER ✦

Effect of recombinant human and mouse interferons on herpes simplex virus type 1 replication in vitro and in vivo: U. Wintergerst,1 J.D. Gangemi2, R.J. Whitley3, E.R. Kern3 and S. Chatterjee3. 1University Children's Hospital, Munich, Germany; 2Clemson University Biomedical Alliance, Clemson, SC, USA; and 3University of Alabama School of Medicine, Birmingham, AL, USA

Book ID: 113259337
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 76 KB
Volume: 26
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(95)94867-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

97 Effect of human recombinant and recom

97 Effect of human recombinant and recombinant hybrid alpha-interferons on the replication of herpes simplex virus type 1 in human fibroblast and neuroblastoma cells: S. Chatterjee1, P. Burns1, J.D. Gangemi2 and R.J. Whitley1. 1Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL, 2Clemson University Biomedical Alliance, Clemson, SC; USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 69 KB

242 Effect of staurosporine on the antiv

242 Effect of staurosporine on the antiviral activity of human interferons: S. Chatterjee1, P. Burns1, J.D. Gangemi2, L. Pirisi3 and R.J. Whitley1. 1Department of Pediatrics, University of Alabama School of Medicine, Birmingham, AL, 2Clemson University Biomedical Alliance, Clemson, SC, 3University of South Carolina, Columbia, SC; USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Effect of CTC-23 on the replication of h

Effect of CTC-23 on the replication of herpes simplex virus type 1 in human fibroblast cells : S. Chatterjee, P. Burns, R.J. Whitley and E.R. Kern, Department of Pediatrics, University of Alabama School of Medicine, Birmingham, Alabama 35294, U.S.A.

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 78 KB

98 Immunoprophylactic strategies for pre

98 Immunoprophylactic strategies for prevention of genital herpes simplex virus infections: J. Palmer1, P.E. Vogt1, M.S. Co2, B. Roizman3, R.J. Whitley1, and E.R. Kern1. 1University of Alabama School of Medicine, Birmingham, AL; 2Protein Design Labs, Mountain View, CA; and 3University of Chicago, Chicago, IL, USA

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Treatment of herpes simplex virus type 2

Treatment of herpes simplex virus type 2 infections in mice with murine and humanized monoclonal antibodies (MABS) : E.R. Kern1, P.E. Vogt1, M.S. Co2, S. Kohl3, and R.J. Whitley1. 1University of Alabama at Birmingham, Birmingham, AL, USA; 2Protein Design Laboratories, Mountain View, CA, USA; and 3University of California at San Francisco, San Francisco, CA, USA

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 83 KB

A novel drug delivery system for the con

A novel drug delivery system for the controlled release of antivirals in combination therapy: J.D. Gangemi1, R. Schinazi2, E.R. Kern3, B. Korba4, J. Corbett5, J. Allen5 and S. Shalaby5. GHSCU Biomedical Cooperative1 and Polymed, Inc.5, Clemson, SC, USA; Emory University, Atlanta, GA2; University of Alabama, Birmingham, AL3, Georgetown University, Rockville, MD4

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 114 KB